Clinical Trial Categories
  • Age & Physical Activity (1)
  • Alzheimer's Disease (7)
  • Arthritis (3)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (16)
  • Cancer - Breast (8)
  • Cancer - Colon/Colorectal (2)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (8)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (6)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (15)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (10)
  • Cancer - Other (5)
  • Cancer - Ovarian (2)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (12)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (2)
  • Dermatomyositis (1)
  • Healthy (6)
  • Hepatitis C (2)
  • HIV (4)
  • HPV (1)
  • Hypercholesterolemia (1)
  • Immune Disease - Autoimmune (9)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Kidney Transplant (1)
  • Liver Disease (2)
  • Lupus Erythematosus (3)
  • Multiple Sclerosis (3)
  • Neurodegenerative (1)
  • OX40 (1)
  • Parkinson's Disease (1)
  • Pediatric (3)
  • Transplant (2)

KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in DTH (9)

Thursday
Feb142013

NCT01910662

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Pruified Protein Derivative (PPD)

Condition: Dermatitis 
Sponsor: GlaxoSmithKline
Phase: 1

Date: DateFebruary 14, 2013
Categories CategoryDermatitis
Tags , , ,
Tuesday
Jun012010

NCT01241682

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

Conditions: Malignant Pleural Mesothelioma
Sponsors: Erasmus Medical Center
Phase I

Date: DateJune 1, 2010 | Reference3 References
Categories CategoryCancer - Mesothelioma
Tags , , ,
Tuesday
Sep012009

NCT00970203

Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Feasibility, Safety and Efficacy Evaluation of Alpha-Type 1 Dendritic Cell(DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With PSA Progression After Local Therapy for Prostate Cancer

Conditions: Prostate Cancer
Sponsor: Pawel Kalinski, University of Pittsburgh
Phase 2 

Date: DateSeptember 1, 2009
Categories CategoryCancer - Prostate
Tags ,
Tuesday
Apr142009

mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Conditions: Uveal Melanoma 
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a

Date: DateApril 14, 2009
Categories CategoryCancer - Melanoma
Tags , , , ,
Tuesday
Jun172008

NCT00700167

Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy

Conditions: Melanoma
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockefeller University
Phase I

Date: DateJune 17, 2008 | Reference1 Reference
Categories CategoryCancer - Melanoma
Tags , ,
Tuesday
Mar252008

NCT00643097

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II

Date: DateMarch 25, 2008 | Reference3 References
Categories CategoryCancer - Brain & CNS
Tags , , , , , , , ,
Friday
Apr062007

PA16215

Immune response to neoantigen and recall antigen in pediatric renal transplant recipients treated with the IL-2Rα monoclonal antibody, daclizumab (Zenapax)

Condition: Renal Transplant
Sponsors: Hoffman-La Roche Inc.
Phase: IV

Date: DateApril 6, 2007
Categories CategoryTransplant
Tags , ,
Wednesday
Oct182006

NCT00390338

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Conditions: Melanoma (Skin)
Sponsors: University of Pittsburgh
Phase I

Date: DateOctober 18, 2006
Categories CategoryCancer - Melanoma
Tags , , ,
Tuesday
Sep272005

NCT00228189

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

Conditions: Colorectal Cancer, Liver Metastases
Sponsors: Radboud University
Phase I, II

Date: DateSeptember 27, 2005 | Reference5 References
Categories CategoryCancer - Colon/Colorectal, CategoryCancer - Liver
Tags , , , ,